Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 7Plasma cell 2Lymphoid 2Thoracic 1CNS 1

Conditions

Multiple Myeloma 3Thrombocytopenia 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Hematologic Neoplasms 1

Interventions

romiplostim 2fludarabine 1eltrombopag 1Surveys and Questionnaires 1Stem Cell Transplantation 1Ritonavir 1Quality of Life 1Metformin 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thrombocytopenia × romiplostim × Plasma cell × Clear all
NCT04478123 2024-02-14

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
62 enrolled 7 charts
Classical hematologyLymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Thrombocytopenia

NCT01676961 2018-10-15

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

NYU Langone Health

Phase 2 Terminated
5 enrolled 4 charts
Classical hematologyPlasma cell

Multiple Myeloma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡